314 related articles for article (PubMed ID: 29929605)
1. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
3. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
4. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
5. Emerging Treatments and Novel Pathways in Pruritus.
Besner Morin C; Misery L
J Cutan Med Surg; 2019; 23(5):528-536. PubMed ID: 31167547
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Neuropathic Itch.
Rosen JD; Fostini AC; Yosipovitch G
Dermatol Clin; 2018 Jul; 36(3):213-224. PubMed ID: 29929594
[TBL] [Abstract][Full Text] [Related]
7. [Modern systemic therapy for pruritus].
Metz M; Pereira MP
Hautarzt; 2020 Jul; 71(7):518-524. PubMed ID: 32399670
[TBL] [Abstract][Full Text] [Related]
8. Current pharmaceutical developments in atopic dermatitis.
Misery L; Huet F; Gouin O; Ständer S; Deleuran M
Curr Opin Pharmacol; 2019 Jun; 46():7-13. PubMed ID: 30611103
[TBL] [Abstract][Full Text] [Related]
9. Emerging Therapeutic Options for Chronic Pruritus.
Reszke R; Krajewski P; Szepietowski JC
Am J Clin Dermatol; 2020 Oct; 21(5):601-618. PubMed ID: 32607945
[TBL] [Abstract][Full Text] [Related]
10. A New Generation of Treatments for Itch.
Fowler E; Yosipovitch G
Acta Derm Venereol; 2020 Jan; 100(2):adv00027. PubMed ID: 31940047
[TBL] [Abstract][Full Text] [Related]
11. Upcoming topical TRPV1 anti-pruritic compounds.
Lee KP; Koshelev MV
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054935
[TBL] [Abstract][Full Text] [Related]
12. Advances in therapeutic strategies for the treatment of pruritus.
Stull C; Lavery MJ; Yosipovitch G
Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350
[TBL] [Abstract][Full Text] [Related]
13. Chronic itch management: therapies beyond those targeting the immune system.
Fowler E; Yosipovitch G
Ann Allergy Asthma Immunol; 2019 Aug; 123(2):158-165. PubMed ID: 30685562
[TBL] [Abstract][Full Text] [Related]
14. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
15. Atopic Dermatitis: Managing the Itch.
Farmer WS; Marathe KS
Adv Exp Med Biol; 2024; 1447():191-207. PubMed ID: 38724794
[TBL] [Abstract][Full Text] [Related]
16. [Therapy for chronic pruritus-light at the end of a long tunnel?].
Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
[TBL] [Abstract][Full Text] [Related]
17. Targeted treatment of pruritus: a look into the future.
Tey HL; Yosipovitch G
Br J Dermatol; 2011 Jul; 165(1):5-17. PubMed ID: 21219293
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging systemic treatments targeting the neural system for chronic pruritus.
Golpanian RS; Yosipovitch G
Expert Opin Pharmacother; 2020 Sep; 21(13):1629-1636. PubMed ID: 32515664
[TBL] [Abstract][Full Text] [Related]
19. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Ständer S; Yosipovitch G
Br J Dermatol; 2019 Nov; 181(5):932-938. PubMed ID: 31016733
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for the treatment of pruritus.
Ständer S; Weisshaar E; Raap U
Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
